We are excited to announce that BTG is now officially part of Boston Scientific. By merging our leading interventional oncology, venous and arterial portfolios, as well as our continuing investment in clinical science and medical education, we are positioned to be a complete clinical partner for our physicians. More importantly, as one organization, we can advance vascular and cancer solutions for more patients around the world. 
BSC and BTG stats
doctor quote

“Through our combination of innovative products, people, and best-in-class capabilities, physicians will be able to extend and improve the lives of more people around the world” 

Jane Healy
VP, Peripheral Interventions EMEA

 

Interventional Oncology

Boston Scientific can now provide interventional radiologists with tools for access and delivery, therapeutic technologies designed to extend and improve life, and clinical evidence to improve patient access to these therapies. 

View our new expanded IO portfolio ›

Interventional Oncology products
 
Venous products
Venous portfolio

Venous

Boston Scientific can now expand the treatment of venous disease, including technology and clinical leadership in the interventional treatment of deep vein thrombosis, pulmonary embolism and deep venous obstruction.

View expanded Venous portfolio ›

 

Arterial

Boston Scientific’s best-in-class arterial portfolio offers differentiated drug-eluting technologies backed by unparalleled clinical evidence, along with a full set of core products to help interventionalists treat the toughest PAD and CLI cases. 

View existing Arterial portfolio ›

Arterial
Customer Support and Service

Customer Support

Our goal is to continue to provide you with the highest level of customer support. For now, there will be no changes to the ordering process, so please continue working with your current Boston Scientific and/or BTG sales representative to order products. We will notify you of changes as soon as we are able.

Read the press release.

Press Release

View the global announcement about Boston Scientific and BTG joining forces. 

Sign up to receive updates

Stay up-to-date 

Receive emails on the latest advances, news and innovations in interventional radiology.

 

Statement of Investment Principles for the BTG Pension Fund SEPT 2020

Download the Implementation Statement
 
 
Top